Bases de datos bibliográficos Pascal y Francis

Ayuda

Resultados de su búsqueda

Su búsqueda

au.\*:("EARLE, C. C")

Año de publicación [py]

A-Z Z-A Frecuencia ↓ Frecuencia ↑
Exportación CSV

Disciplina (documento) [di]

A-Z Z-A Frecuencia ↓ Frecuencia ↑
Exportación CSV

Resultados 1 a 13 de 13

  • Página / 1
Exportación

Selección :

  • y

Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastastic colorectal cancerMEYERHARDT, J. A; STUART, K; LAWRENCE, C et al.Annals of oncology. 2007, Vol 18, Num 7, pp 1185-1189, issn 0923-7534, 5 p.Article

Economic decision analysis model of screening for lung cancerMARSHALL, D; SIMPSON, K. N; EARLE, C. C et al.European journal of cancer (1990). 2001, Vol 37, Num 14, pp 1759-1767, issn 0959-8049Article

Outcomes research in oncology : History, conceptual framework, and trends in the literatureLEE, S. J; EARLE, C. C; WEEKS, J. C et al.Journal of the National Cancer Institute. 2000, Vol 92, Num 3, pp 195-204, issn 0027-8874Article

Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients : Revisiting a meta-analysis of randomised trialsEARLE, C. C; MAROUN, J. A.European journal of cancer (1990). 1999, Vol 35, Num 7, pp 1059-1064, issn 0959-8049Article

Cost of combined modality interventions for stage III non-small-cell lung cancerEVANS, W. K; WILL, B. P; BERTHELOT, J.-M et al.Journal of clinical oncology. 1997, Vol 15, Num 9, pp 3038-3048, issn 0732-183XArticle

Weekly docetaxel, cisplatin, and irinotecan (TPC) : results of a multicenter phase II trial in patients with metastatic esophagogastric cancerENZINGER, P. C; RYAN, D. P; VINCITORE, M. M et al.Annals of oncology. 2009, Vol 20, Num 3, pp 475-480, issn 0923-7534, 6 p.Article

Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors : decision analysis and cost-effectiveness analysisDAS, P; NG, A. K; EARLE, C. C et al.Annals of oncology. 2006, Vol 17, Num 5, pp 785-793, issn 0923-7534, 9 p.Article

Cost-effectiveness analysis in oncologyEARLE, C. C; COYLE, D; EVANS, W. K et al.Annals of oncology. 1998, Vol 9, Num 5, pp 475-482, issn 0923-7534Article

Systematic overview of cost-utility assessments in oncologyEARLE, C. C; CHAPMAN, R. H; BAKER, C. S et al.Journal of clinical oncology. 2000, Vol 18, Num 18, pp 3302-3317, issn 0732-183XArticle

A phase I study of gemcitabine/cisplatin/etoposide in the treatment of small-cell lung cancerEARLE, C. C; STEWART, D. J; CORMIER, Y et al.Lung cancer. 1998, Vol 22, Num 3, pp 235-241, issn 0169-5002Article

Marital status and survival following bladder cancerDABRAL DATTA, G; NEVILLE, B. A; KAWACHI, I et al.Journal of epidemiology and community health (1979). 2009, Vol 63, Num 10, pp 807-813, issn 0143-005X, 7 p.Article

Cancer physicians' attitudes toward colorectal cancer follow-upEARLE, C. C; GRUNFELD, E; COYLE, D et al.Annals of oncology. 2003, Vol 14, Num 3, pp 400-405, issn 0923-7534, 6 p.Article

Cost-effectiveness of paclitaxel plus cisplatin in advanced non-small-cell lung cancerEARLE, C. C; EVANS, W. K.British journal of cancer. 1999, Vol 80, Num 5-6, pp 815-820, issn 0007-0920Article

  • Página / 1